BIT 9.09% 3.0¢ biotron limited

johnson & johnson, page-16

  1. J8
    14,548 Posts.
    lightbulb Created with Sketch. 822
    Not sure that its all over for Biotron, just difficulty finding a market in time.

    BLT owns the IP for ddRNAi. They have a platform not a drug.

    BLT is only just beginning to prove itself as the superior gene silencing technology. Their HCV trial, if successful will carve a niche out in the market through effectivenes and price. It is fair to say that the DAAs from Gilead and Abbvie have the jump in the HCV space. Benitec are not a one trick pony and do not compare with Biotron in any way.

    I am not here to push them but to keep interested people informed and hopefully learn more myself while I am at it.
 
watchlist Created with Sketch. Add BIT (ASX) to my watchlist
(20min delay)
Last
3.0¢
Change
-0.003(9.09%)
Mkt cap ! $27.06M
Open High Low Value Volume
3.3¢ 3.4¢ 3.0¢ $32.26K 1.016M

Buyers (Bids)

No. Vol. Price($)
14 720804 3.0¢
 

Sellers (Offers)

Price($) Vol. No.
3.1¢ 30000 1
View Market Depth
Last trade - 16.10pm 25/07/2024 (20 minute delay) ?
BIT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.